Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) Shares Outstanding (Weighted Average): 2012-2025

Historic Shares Outstanding (Weighted Average) for Ptc Therapeutics (PTCT) over the last 13 years, with Sep 2025 value amounting to $79.4 million.

  • Ptc Therapeutics' Shares Outstanding (Weighted Average) rose 3.27% to $79.4 million in Q3 2025 from the same period last year, while for Dec 2024 it was $77.1 million, marking a year-over-year increase of 2.20%. This contributed to the annual value of $77.1 million for FY2024, which is 2.20% up from last year.
  • According to the latest figures from Q3 2025, Ptc Therapeutics' Shares Outstanding (Weighted Average) is $79.4 million, which was up 0.23% from $79.3 million recorded in Q2 2025.
  • Ptc Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $79.4 million for Q3 2025, and its period low was $70.3 million during Q1 2021.
  • Over the past 3 years, Ptc Therapeutics' median Shares Outstanding (Weighted Average) value was $76.7 million (recorded in 2024), while the average stood at $76.7 million.
  • Data for Ptc Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 12.28% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Ptc Therapeutics' Shares Outstanding (Weighted Average) stood at $70.7 million in 2021, then grew by 1.67% to $71.9 million in 2022, then grew by 4.98% to $75.5 million in 2023, then climbed by 2.20% to $77.1 million in 2024, then grew by 3.27% to $79.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $79.4 million for Q3 2025, versus $79.3 million for Q2 2025 and $78.9 million for Q1 2025.